GlassScriptPhysician profile
Carla Evans
NPI 1083945653
$1,626.35
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $670 · 2022: $505 · 2023: $277 · 2024: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $452.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $451.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $287.89 | 2021-2023 | |
| Bardy Diagnostics, INC. | $222.08 | 2021-2022 | |
| Abbott Laboratories | $208.72 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $179.53 | 2021-2023 | Jardiance |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $113.54 | 2024 | Caplyta |
| Astrazeneca Pharmaceuticals LP | $101.32 | 2022-2023 | Farxiga |
| Novartis Pharmaceuticals Corporation | $94.45 | 2022-2023 | |
| Amgen INC. | $93.52 | 2021-2024 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $78.05 | 2022-2023 | Eliquis |
| Medtronic, INC. | $62.29 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $38.52 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $34.59 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $22.59 | 2023 | Uptravi, Opsumit |
| Boston Scientific Corporation | $22.25 | 2022 | |
| Edwards Lifesciences Corporation | $20.41 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $17.24 | 2023 | Abilify Maintena |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.94 | 2022 | |
| Tactile Systems Technology INC | $14.42 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carla Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.